SCHEMBL4126600

SCHEMBL4126600

Cn1nccc1-c1cc(N)ccc1OCCC1CCCN1

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 19/20 0.41
HTR2C P28335 18/20 0.41
MKNK1 Q9BUB5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3952777 0.97 HTR2A (0.41) HTR2AHTR2C
SCHEMBL5243204 0.85 HTR2A (0.46) HTR2AHTR2C
SCHEMBL4791807 0.85 MKNK1 (0.41) MKNK1
SCHEMBL5244379 0.83 CHEK2 (0.49) HTR2AHTR2C
SCHEMBL5243786 0.82 HTR2A (0.56) HTR2AHTR2C
SCHEMBL5243079 0.81 HTR2A (0.44) HTR2AHTR2CMKNK1
SCHEMBL14067170 0.80 KDM4E (0.50) HTR2AHTR2C
SCHEMBL5245210 0.80 HTR2A (0.55) HTR2AHTR2C
SCHEMBL1166182 0.79 HTR2A (0.60) HTR2AHTR2C
SCHEMBL1166912 0.79 HTR2A (0.60) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP disclosed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO disclosed
EP-1833799-A2 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2007-09-19 EP disclosed
WO-2006055734-A2 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2006-05-26 WO disclosed